Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-randomized, Multicenter Study to Assess the Efficacy and Safety of Oral or Intravenous Paricalcitol Administered Over 6 Months to Patients With Secondary Hyperparathyroidism on Dialysis

NCT00537979 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00537979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-randomized, Multicenter Study to Assess the Efficacy and Safety of Oral or Intravenous Paricalcitol Administered Over 6 Months to Patients With Secondary Hyperparathyroidism on Dialysis
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
July 31, 2010
Enrollment
147 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis, secondary hyperparathyroidism